EyePoint Pharmaceuticals Inc
(FRA:PV3B)
€
7.932
0.038 (0.48%)
Market Cap: 409.05 Mil
Enterprise Value: 136.42 Mil
PE Ratio: 0
PB Ratio: 1.69
GF Score: 61/100 EyePoint Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 30, 2021 / 03:55PM GMT
Brent Slava
Benzinga - Media
All right, next up. We are ready to go with the next one, ladies and gentlemen. We have EyePoint Pharmaceuticals. It is ticker EYPT, and we have the CEO, who is about to come on here in a second, Nancy Lurker. Nancy, are you out there?
Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO
Hi.
Brent Slava
Benzinga - Media
Hi.
Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO
Can you see me? Because I'm sharing my screen, but I can see you guys.
Brent Slava
Benzinga - Media
I can see you. You look great, you sound great, I'll let you have the floor.
Nancy Lurker
EyePoint Pharmaceuticals, Inc. - President & CEO
Okay, great. Can you just remind me, just quickly, how much time I have, because I want to try to stay on time here.
Brent Slava
Benzinga - Media
Yes, I really
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot